Format

Send to

Choose Destination
Trends Mol Med. 2001 Mar;7(3):115-21.

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

Author information

1
Division of Neuroimmunology, Brain Research Institute, University of Vienna, Spitalgasse 4, A-1090, Wien, Austria. hans.lassman@univie.ac.at

Abstract

Multiple sclerosis is a chronic inflammatory disease of the nervous system in which a T-cell-mediated inflammatory process is associated with destruction of myelin sheaths. Although demyelination is the primary event, axons are also destroyed in the lesions, and the loss of axons correlates with permanent functional deficit. Here, we discuss evidence that demyelination and axonal destruction follow different pathogenetic pathways in subgroups of patients. This might, at least in part, explain the heterogeneity in genetic susceptibility, clinical presentation and response to treatment observed between individuals.

PMID:
11286782
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center